nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—FGFR3—skull—Paget's disease of bone	0.00875	0.397	CbGeAlD
Pazopanib—ITK—Class I PI3K signaling events—INPP5D—Paget's disease of bone	0.00828	0.0214	CbGpPWpGaD
Pazopanib—PDGFRB—Osteoblast Signaling—TNFRSF11B—Paget's disease of bone	0.00791	0.0204	CbGpPWpGaD
Pazopanib—PDGFRA—Osteoblast Signaling—BGLAP—Paget's disease of bone	0.00788	0.0203	CbGpPWpGaD
Pazopanib—CSF1R—Differentiation Pathway—CSF1—Paget's disease of bone	0.00786	0.0203	CbGpPWpGaD
Pazopanib—LYN—PECAM1 interactions—INPP5D—Paget's disease of bone	0.00754	0.0194	CbGpPWpGaD
Pazopanib—CSF1R—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.00737	0.019	CbGpPWpGaD
Pazopanib—PDGFRB—Osteoblast Signaling—BGLAP—Paget's disease of bone	0.0071	0.0183	CbGpPWpGaD
Pazopanib—ITK—TCR signaling—INPP5D—Paget's disease of bone	0.00667	0.0172	CbGpPWpGaD
Pazopanib—PLK4—Regulation of PLK1 Activity at G2/M Transition—OPTN—Paget's disease of bone	0.00649	0.0168	CbGpPWpGaD
Pazopanib—ITK—Fc-epsilon receptor I signaling in mast cells—INPP5D—Paget's disease of bone	0.00649	0.0167	CbGpPWpGaD
Pazopanib—CSF1R—Integrins in angiogenesis—CSF1—Paget's disease of bone	0.00632	0.0163	CbGpPWpGaD
Pazopanib—LCK—PECAM1 interactions—INPP5D—Paget's disease of bone	0.00618	0.0159	CbGpPWpGaD
Pazopanib—ITK—TCR signaling in naïve CD4+ T cells—INPP5D—Paget's disease of bone	0.00609	0.0157	CbGpPWpGaD
Pazopanib—LYN—RANKL/RANK Signaling Pathway—TNFRSF11A—Paget's disease of bone	0.00596	0.0154	CbGpPWpGaD
Pazopanib—KDR—Signaling events mediated by TCPTP—CSF1—Paget's disease of bone	0.00586	0.0151	CbGpPWpGaD
Pazopanib—FGFR2—skull—Paget's disease of bone	0.00573	0.26	CbGeAlD
Pazopanib—PLK4—G2/M Transition—OPTN—Paget's disease of bone	0.00488	0.0126	CbGpPWpGaD
Pazopanib—FGF1—Differentiation Pathway—CSF1—Paget's disease of bone	0.00483	0.0125	CbGpPWpGaD
Pazopanib—PLK4—Mitotic G2-G2/M phases—OPTN—Paget's disease of bone	0.00481	0.0124	CbGpPWpGaD
Pazopanib—MAP3K2—IL-1 signaling pathway—SQSTM1—Paget's disease of bone	0.00479	0.0124	CbGpPWpGaD
Pazopanib—PI4KB—Phospholipid metabolism—INPP5D—Paget's disease of bone	0.00446	0.0115	CbGpPWpGaD
Pazopanib—FGFR3—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00418	0.0108	CbGpPWpGaD
Pazopanib—KDR—Integrins in angiogenesis—CSF1—Paget's disease of bone	0.00408	0.0105	CbGpPWpGaD
Pazopanib—KDR—Notch-mediated HES/HEY network—BGLAP—Paget's disease of bone	0.00407	0.0105	CbGpPWpGaD
Pazopanib—FGFR3—Endochondral Ossification—ALPL—Paget's disease of bone	0.00394	0.0102	CbGpPWpGaD
Pazopanib—KIT—Differentiation Pathway—CSF1—Paget's disease of bone	0.00393	0.0101	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling events mediated by TCPTP—CSF1—Paget's disease of bone	0.00388	0.01	CbGpPWpGaD
Pazopanib—UGT1A1—urine—Paget's disease of bone	0.00362	0.165	CbGeAlD
Pazopanib—FGF1—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00348	0.00897	CbGpPWpGaD
Pazopanib—LYN—EPO signaling pathway—INPP5D—Paget's disease of bone	0.00344	0.00887	CbGpPWpGaD
Pazopanib—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00338	0.00573	CcSEcCtD
Pazopanib—Musculoskeletal pain—Zoledronate—Paget's disease of bone	0.00334	0.00565	CcSEcCtD
Pazopanib—Abdominal pain—Tiludronate—Paget's disease of bone	0.00327	0.00554	CcSEcCtD
Pazopanib—Dry skin—Alendronate—Paget's disease of bone	0.00315	0.00533	CcSEcCtD
Pazopanib—PDGFRB—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.00314	0.00811	CbGpPWpGaD
Pazopanib—Blood urea increased—Zoledronate—Paget's disease of bone	0.00311	0.00527	CcSEcCtD
Pazopanib—LIMK2—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.00308	0.00796	CbGpPWpGaD
Pazopanib—LYN—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.00308	0.00794	CbGpPWpGaD
Pazopanib—LYN—GMCSF-mediated signaling events—INPP5D—Paget's disease of bone	0.00306	0.0079	CbGpPWpGaD
Pazopanib—Hepatic function abnormal—Pamidronate—Paget's disease of bone	0.003	0.00508	CcSEcCtD
Pazopanib—Abdominal distension—Alendronate—Paget's disease of bone	0.00299	0.00506	CcSEcCtD
Pazopanib—Asthenia—Tiludronate—Paget's disease of bone	0.00297	0.00503	CcSEcCtD
Pazopanib—TAOK1—M Phase—NUP205—Paget's disease of bone	0.00295	0.0076	CbGpPWpGaD
Pazopanib—Cardiac failure congestive—Pamidronate—Paget's disease of bone	0.00289	0.00489	CcSEcCtD
Pazopanib—FGFR2—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00288	0.00742	CbGpPWpGaD
Pazopanib—TAOK1—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.00284	0.00733	CbGpPWpGaD
Pazopanib—Diarrhoea—Tiludronate—Paget's disease of bone	0.00283	0.00479	CcSEcCtD
Pazopanib—MAP3K2—BDNF signaling pathway—ALPL—Paget's disease of bone	0.00279	0.00719	CbGpPWpGaD
Pazopanib—Dizziness—Tiludronate—Paget's disease of bone	0.00273	0.00463	CcSEcCtD
Pazopanib—Photosensitivity reaction—Alendronate—Paget's disease of bone	0.00271	0.00459	CcSEcCtD
Pazopanib—TAOK1—Mitotic M-M/G1 phases—NUP205—Paget's disease of bone	0.0027	0.00697	CbGpPWpGaD
Pazopanib—Cardiac failure—Pamidronate—Paget's disease of bone	0.00268	0.00455	CcSEcCtD
Pazopanib—FGFR1—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00268	0.00692	CbGpPWpGaD
Pazopanib—Lethargy—Pamidronate—Paget's disease of bone	0.00267	0.00453	CcSEcCtD
Pazopanib—LYN—Interleukin-3, 5 and GM-CSF signaling—INPP5D—Paget's disease of bone	0.00266	0.00687	CbGpPWpGaD
Pazopanib—Gastrointestinal haemorrhage—Pamidronate—Paget's disease of bone	0.00262	0.00444	CcSEcCtD
Pazopanib—LYN—Class I PI3K signaling events—INPP5D—Paget's disease of bone	0.00262	0.00675	CbGpPWpGaD
Pazopanib—LYN—RANKL/RANK Signaling Pathway—TNFRSF11B—Paget's disease of bone	0.00259	0.00669	CbGpPWpGaD
Pazopanib—Headache—Tiludronate—Paget's disease of bone	0.00259	0.00439	CcSEcCtD
Pazopanib—Stomatitis—Alendronate—Paget's disease of bone	0.00258	0.00437	CcSEcCtD
Pazopanib—Liver function test abnormal—Risedronate—Paget's disease of bone	0.00254	0.00431	CcSEcCtD
Pazopanib—TAOK1—Cell Cycle—OPTN—Paget's disease of bone	0.00254	0.00656	CbGpPWpGaD
Pazopanib—FGFR1—Endochondral Ossification—ALPL—Paget's disease of bone	0.00253	0.00652	CbGpPWpGaD
Pazopanib—LIMK2—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00253	0.00652	CbGpPWpGaD
Pazopanib—KIT—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.00252	0.00651	CbGpPWpGaD
Pazopanib—LCK—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.00252	0.0065	CbGpPWpGaD
Pazopanib—Abdominal pain upper—Risedronate—Paget's disease of bone	0.00252	0.00426	CcSEcCtD
Pazopanib—Breast disorder—Risedronate—Paget's disease of bone	0.00249	0.00422	CcSEcCtD
Pazopanib—Nasopharyngitis—Risedronate—Paget's disease of bone	0.00246	0.00417	CcSEcCtD
Pazopanib—Alopecia—Etidronic acid—Paget's disease of bone	0.00246	0.00417	CcSEcCtD
Pazopanib—Nausea—Tiludronate—Paget's disease of bone	0.00246	0.00416	CcSEcCtD
Pazopanib—Blood creatinine increased—Pamidronate—Paget's disease of bone	0.00245	0.00416	CcSEcCtD
Pazopanib—LYN—IL-3 Signaling Pathway—INPP5D—Paget's disease of bone	0.00244	0.00631	CbGpPWpGaD
Pazopanib—Lethargy—Zoledronate—Paget's disease of bone	0.00244	0.00414	CcSEcCtD
Pazopanib—Erythema—Etidronic acid—Paget's disease of bone	0.00243	0.00411	CcSEcCtD
Pazopanib—Liver function test abnormal—Pamidronate—Paget's disease of bone	0.00242	0.0041	CcSEcCtD
Pazopanib—Abdominal distension—Risedronate—Paget's disease of bone	0.0024	0.00406	CcSEcCtD
Pazopanib—Flatulence—Etidronic acid—Paget's disease of bone	0.00239	0.00405	CcSEcCtD
Pazopanib—Haemoglobin—Alendronate—Paget's disease of bone	0.00239	0.00404	CcSEcCtD
Pazopanib—Haemorrhage—Alendronate—Paget's disease of bone	0.00238	0.00402	CcSEcCtD
Pazopanib—Nasopharyngitis—Pamidronate—Paget's disease of bone	0.00234	0.00397	CcSEcCtD
Pazopanib—Oedema peripheral—Alendronate—Paget's disease of bone	0.00234	0.00396	CcSEcCtD
Pazopanib—Muscle spasms—Etidronic acid—Paget's disease of bone	0.00233	0.00395	CcSEcCtD
Pazopanib—LCK—Downstream TCR signaling—INPP5D—Paget's disease of bone	0.00231	0.00596	CbGpPWpGaD
Pazopanib—MAP3K2—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00225	0.00581	CbGpPWpGaD
Pazopanib—Anaemia—Etidronic acid—Paget's disease of bone	0.00224	0.0038	CcSEcCtD
Pazopanib—Blood creatinine increased—Zoledronate—Paget's disease of bone	0.00224	0.0038	CcSEcCtD
Pazopanib—Dehydration—Zoledronate—Paget's disease of bone	0.00222	0.00377	CcSEcCtD
Pazopanib—MAP3K2—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.00222	0.00572	CbGpPWpGaD
Pazopanib—Abdominal pain upper—Zoledronate—Paget's disease of bone	0.00218	0.0037	CcSEcCtD
Pazopanib—Leukopenia—Etidronic acid—Paget's disease of bone	0.00217	0.00368	CcSEcCtD
Pazopanib—LCK—Class I PI3K signaling events—INPP5D—Paget's disease of bone	0.00215	0.00553	CbGpPWpGaD
Pazopanib—Nasopharyngitis—Zoledronate—Paget's disease of bone	0.00214	0.00362	CcSEcCtD
Pazopanib—Infestation NOS—Risedronate—Paget's disease of bone	0.00212	0.0036	CcSEcCtD
Pazopanib—Infestation—Risedronate—Paget's disease of bone	0.00212	0.0036	CcSEcCtD
Pazopanib—Neutropenia—Pamidronate—Paget's disease of bone	0.00212	0.00359	CcSEcCtD
Pazopanib—LYN—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.00211	0.00544	CbGpPWpGaD
Pazopanib—Alopecia—Alendronate—Paget's disease of bone	0.0021	0.00356	CcSEcCtD
Pazopanib—Abdominal distension—Zoledronate—Paget's disease of bone	0.00208	0.00353	CcSEcCtD
Pazopanib—LCK—Interleukin-2 signaling—INPP5D—Paget's disease of bone	0.00207	0.00534	CbGpPWpGaD
Pazopanib—Erythema—Alendronate—Paget's disease of bone	0.00207	0.0035	CcSEcCtD
Pazopanib—Arthralgia—Etidronic acid—Paget's disease of bone	0.00207	0.0035	CcSEcCtD
Pazopanib—LYN—Fc-epsilon receptor I signaling in mast cells—INPP5D—Paget's disease of bone	0.00205	0.00529	CbGpPWpGaD
Pazopanib—Flatulence—Alendronate—Paget's disease of bone	0.00204	0.00345	CcSEcCtD
Pazopanib—Dysgeusia—Alendronate—Paget's disease of bone	0.00202	0.00343	CcSEcCtD
Pazopanib—TAOK1—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.00202	0.00521	CbGpPWpGaD
Pazopanib—Infestation—Pamidronate—Paget's disease of bone	0.00202	0.00342	CcSEcCtD
Pazopanib—Infestation NOS—Pamidronate—Paget's disease of bone	0.00202	0.00342	CcSEcCtD
Pazopanib—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00201	0.0034	CcSEcCtD
Pazopanib—LYN—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.002	0.00515	CbGpPWpGaD
Pazopanib—Muscle spasms—Alendronate—Paget's disease of bone	0.00199	0.00337	CcSEcCtD
Pazopanib—Infection—Etidronic acid—Paget's disease of bone	0.00197	0.00333	CcSEcCtD
Pazopanib—Stomatitis—Pamidronate—Paget's disease of bone	0.00197	0.00333	CcSEcCtD
Pazopanib—Neutropenia—Zoledronate—Paget's disease of bone	0.00193	0.00328	CcSEcCtD
Pazopanib—Haematuria—Pamidronate—Paget's disease of bone	0.00192	0.00326	CcSEcCtD
Pazopanib—Haemoglobin—Risedronate—Paget's disease of bone	0.00192	0.00325	CcSEcCtD
Pazopanib—Anaemia—Alendronate—Paget's disease of bone	0.00191	0.00324	CcSEcCtD
Pazopanib—Haemorrhage—Risedronate—Paget's disease of bone	0.00191	0.00323	CcSEcCtD
Pazopanib—LYN—BCR signaling pathway—INPP5D—Paget's disease of bone	0.0019	0.00491	CbGpPWpGaD
Pazopanib—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00188	0.00319	CcSEcCtD
Pazopanib—Oedema peripheral—Risedronate—Paget's disease of bone	0.00188	0.00318	CcSEcCtD
Pazopanib—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00187	0.00317	CcSEcCtD
Pazopanib—Weight decreased—Zoledronate—Paget's disease of bone	0.00187	0.00317	CcSEcCtD
Pazopanib—Urethral disorder—Risedronate—Paget's disease of bone	0.00187	0.00316	CcSEcCtD
Pazopanib—SH2B3—Hemostasis—INPP5D—Paget's disease of bone	0.00185	0.00478	CbGpPWpGaD
Pazopanib—Infestation—Zoledronate—Paget's disease of bone	0.00184	0.00312	CcSEcCtD
Pazopanib—Infestation NOS—Zoledronate—Paget's disease of bone	0.00184	0.00312	CcSEcCtD
Pazopanib—MAP2K5—BDNF signaling pathway—ALPL—Paget's disease of bone	0.00184	0.00475	CbGpPWpGaD
Pazopanib—Haemoglobin—Pamidronate—Paget's disease of bone	0.00182	0.00308	CcSEcCtD
Pazopanib—Haemorrhage—Pamidronate—Paget's disease of bone	0.00181	0.00307	CcSEcCtD
Pazopanib—TAOK1—Cell Cycle—NUP205—Paget's disease of bone	0.00181	0.00466	CbGpPWpGaD
Pazopanib—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.0018	0.00306	CcSEcCtD
Pazopanib—Stomatitis—Zoledronate—Paget's disease of bone	0.0018	0.00304	CcSEcCtD
Pazopanib—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00179	0.00303	CcSEcCtD
Pazopanib—Eye disorder—Risedronate—Paget's disease of bone	0.00178	0.00302	CcSEcCtD
Pazopanib—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00178	0.00302	CcSEcCtD
Pazopanib—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00178	0.00301	CcSEcCtD
Pazopanib—Urethral disorder—Pamidronate—Paget's disease of bone	0.00178	0.00301	CcSEcCtD
Pazopanib—Cardiac disorder—Risedronate—Paget's disease of bone	0.00177	0.003	CcSEcCtD
Pazopanib—Chest pain—Alendronate—Paget's disease of bone	0.00176	0.00298	CcSEcCtD
Pazopanib—Myalgia—Alendronate—Paget's disease of bone	0.00176	0.00298	CcSEcCtD
Pazopanib—Haematuria—Zoledronate—Paget's disease of bone	0.00176	0.00298	CcSEcCtD
Pazopanib—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00174	0.00295	CcSEcCtD
Pazopanib—Angiopathy—Risedronate—Paget's disease of bone	0.00173	0.00293	CcSEcCtD
Pazopanib—LCK—TCR signaling—INPP5D—Paget's disease of bone	0.00173	0.00446	CbGpPWpGaD
Pazopanib—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00172	0.00291	CcSEcCtD
Pazopanib—Eye disorder—Pamidronate—Paget's disease of bone	0.00169	0.00287	CcSEcCtD
Pazopanib—Bradycardia—Zoledronate—Paget's disease of bone	0.00168	0.00285	CcSEcCtD
Pazopanib—Flushing—Pamidronate—Paget's disease of bone	0.00168	0.00285	CcSEcCtD
Pazopanib—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00168	0.00285	CcSEcCtD
Pazopanib—Infection—Alendronate—Paget's disease of bone	0.00168	0.00284	CcSEcCtD
Pazopanib—Mental disorder—Risedronate—Paget's disease of bone	0.00167	0.00283	CcSEcCtD
Pazopanib—Malnutrition—Risedronate—Paget's disease of bone	0.00166	0.00281	CcSEcCtD
Pazopanib—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00165	0.00279	CcSEcCtD
Pazopanib—Angiopathy—Pamidronate—Paget's disease of bone	0.00164	0.00278	CcSEcCtD
Pazopanib—Flatulence—Risedronate—Paget's disease of bone	0.00163	0.00277	CcSEcCtD
Pazopanib—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00163	0.00277	CcSEcCtD
Pazopanib—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00163	0.00277	CcSEcCtD
Pazopanib—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00163	0.00276	CcSEcCtD
Pazopanib—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00163	0.00275	CcSEcCtD
Pazopanib—Chills—Pamidronate—Paget's disease of bone	0.00163	0.00275	CcSEcCtD
Pazopanib—Urethral disorder—Zoledronate—Paget's disease of bone	0.00162	0.00275	CcSEcCtD
Pazopanib—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00162	0.00274	CcSEcCtD
Pazopanib—CYP1A2—urine—Paget's disease of bone	0.0016	0.0729	CbGeAlD
Pazopanib—Alopecia—Pamidronate—Paget's disease of bone	0.0016	0.00271	CcSEcCtD
Pazopanib—Muscle spasms—Risedronate—Paget's disease of bone	0.0016	0.0027	CcSEcCtD
Pazopanib—LYN—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.00159	0.0041	CbGpPWpGaD
Pazopanib—LCK—TCR signaling in naïve CD4+ T cells—INPP5D—Paget's disease of bone	0.00158	0.00407	CbGpPWpGaD
Pazopanib—Malnutrition—Pamidronate—Paget's disease of bone	0.00158	0.00267	CcSEcCtD
Pazopanib—Erythema—Pamidronate—Paget's disease of bone	0.00158	0.00267	CcSEcCtD
Pazopanib—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00157	0.00265	CcSEcCtD
Pazopanib—PLK4—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.00155	0.004	CbGpPWpGaD
Pazopanib—Eye disorder—Zoledronate—Paget's disease of bone	0.00155	0.00262	CcSEcCtD
Pazopanib—Dysgeusia—Pamidronate—Paget's disease of bone	0.00154	0.00262	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00154	0.0026	CcSEcCtD
Pazopanib—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00154	0.0026	CcSEcCtD
Pazopanib—Flushing—Zoledronate—Paget's disease of bone	0.00154	0.0026	CcSEcCtD
Pazopanib—Anaemia—Risedronate—Paget's disease of bone	0.00153	0.0026	CcSEcCtD
Pazopanib—Muscle spasms—Pamidronate—Paget's disease of bone	0.00152	0.00257	CcSEcCtD
Pazopanib—FGFR2—Ectoderm Differentiation—TNFRSF11B—Paget's disease of bone	0.00151	0.00391	CbGpPWpGaD
Pazopanib—Angiopathy—Zoledronate—Paget's disease of bone	0.0015	0.00254	CcSEcCtD
Pazopanib—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00149	0.00253	CcSEcCtD
Pazopanib—MAP2K5—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00149	0.00384	CbGpPWpGaD
Pazopanib—Syncope—Risedronate—Paget's disease of bone	0.00149	0.00252	CcSEcCtD
Pazopanib—Dyspepsia—Alendronate—Paget's disease of bone	0.00149	0.00252	CcSEcCtD
Pazopanib—Chills—Zoledronate—Paget's disease of bone	0.00148	0.00252	CcSEcCtD
Pazopanib—MAP2K5—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.00147	0.00378	CbGpPWpGaD
Pazopanib—Alopecia—Zoledronate—Paget's disease of bone	0.00146	0.00248	CcSEcCtD
Pazopanib—Loss of consciousness—Risedronate—Paget's disease of bone	0.00146	0.00247	CcSEcCtD
Pazopanib—Anaemia—Pamidronate—Paget's disease of bone	0.00146	0.00247	CcSEcCtD
Pazopanib—Mental disorder—Zoledronate—Paget's disease of bone	0.00145	0.00246	CcSEcCtD
Pazopanib—Cough—Risedronate—Paget's disease of bone	0.00145	0.00245	CcSEcCtD
Pazopanib—Pain—Alendronate—Paget's disease of bone	0.00144	0.00244	CcSEcCtD
Pazopanib—Malnutrition—Zoledronate—Paget's disease of bone	0.00144	0.00244	CcSEcCtD
Pazopanib—Erythema—Zoledronate—Paget's disease of bone	0.00144	0.00244	CcSEcCtD
Pazopanib—PI4KB—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.00143	0.0037	CbGpPWpGaD
Pazopanib—Hypertension—Risedronate—Paget's disease of bone	0.00143	0.00243	CcSEcCtD
Pazopanib—LYN—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.00142	0.00365	CbGpPWpGaD
Pazopanib—Syncope—Pamidronate—Paget's disease of bone	0.00141	0.0024	CcSEcCtD
Pazopanib—Arthralgia—Risedronate—Paget's disease of bone	0.00141	0.00239	CcSEcCtD
Pazopanib—Chest pain—Risedronate—Paget's disease of bone	0.00141	0.00239	CcSEcCtD
Pazopanib—Myalgia—Risedronate—Paget's disease of bone	0.00141	0.00239	CcSEcCtD
Pazopanib—Leukopenia—Pamidronate—Paget's disease of bone	0.00141	0.00239	CcSEcCtD
Pazopanib—Dysgeusia—Zoledronate—Paget's disease of bone	0.00141	0.00239	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.0014	0.00238	CcSEcCtD
Pazopanib—Pruritus—Etidronic acid—Paget's disease of bone	0.0014	0.00237	CcSEcCtD
Pazopanib—LYN—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.00139	0.00359	CbGpPWpGaD
Pazopanib—PLK4—Cell Cycle—OPTN—Paget's disease of bone	0.00139	0.00358	CbGpPWpGaD
Pazopanib—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00139	0.00235	CcSEcCtD
Pazopanib—Muscle spasms—Zoledronate—Paget's disease of bone	0.00139	0.00235	CcSEcCtD
Pazopanib—Dry mouth—Risedronate—Paget's disease of bone	0.00138	0.00234	CcSEcCtD
Pazopanib—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00138	0.00234	CcSEcCtD
Pazopanib—Cough—Pamidronate—Paget's disease of bone	0.00138	0.00233	CcSEcCtD
Pazopanib—Hypertension—Pamidronate—Paget's disease of bone	0.00136	0.00231	CcSEcCtD
Pazopanib—Vision blurred—Zoledronate—Paget's disease of bone	0.00136	0.0023	CcSEcCtD
Pazopanib—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00136	0.0023	CcSEcCtD
Pazopanib—Infection—Risedronate—Paget's disease of bone	0.00135	0.00228	CcSEcCtD
Pazopanib—Myalgia—Pamidronate—Paget's disease of bone	0.00134	0.00227	CcSEcCtD
Pazopanib—Arthralgia—Pamidronate—Paget's disease of bone	0.00134	0.00227	CcSEcCtD
Pazopanib—Abdominal pain—Alendronate—Paget's disease of bone	0.00133	0.00226	CcSEcCtD
Pazopanib—Shock—Risedronate—Paget's disease of bone	0.00133	0.00226	CcSEcCtD
Pazopanib—Anaemia—Zoledronate—Paget's disease of bone	0.00133	0.00226	CcSEcCtD
Pazopanib—Nervous system disorder—Risedronate—Paget's disease of bone	0.00133	0.00225	CcSEcCtD
Pazopanib—Skin disorder—Risedronate—Paget's disease of bone	0.00132	0.00223	CcSEcCtD
Pazopanib—LCK—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.0013	0.00336	CbGpPWpGaD
Pazopanib—LYN—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.0013	0.00335	CbGpPWpGaD
Pazopanib—Syncope—Zoledronate—Paget's disease of bone	0.00129	0.00219	CcSEcCtD
Pazopanib—Leukopenia—Zoledronate—Paget's disease of bone	0.00129	0.00218	CcSEcCtD
Pazopanib—Oedema—Pamidronate—Paget's disease of bone	0.00129	0.00218	CcSEcCtD
Pazopanib—Infection—Pamidronate—Paget's disease of bone	0.00128	0.00217	CcSEcCtD
Pazopanib—Shock—Pamidronate—Paget's disease of bone	0.00127	0.00215	CcSEcCtD
Pazopanib—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00127	0.00214	CcSEcCtD
Pazopanib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00126	0.00214	CcSEcCtD
Pazopanib—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00126	0.00213	CcSEcCtD
Pazopanib—Vomiting—Etidronic acid—Paget's disease of bone	0.00126	0.00213	CcSEcCtD
Pazopanib—FGF1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00126	0.00324	CbGpPWpGaD
Pazopanib—Cough—Zoledronate—Paget's disease of bone	0.00126	0.00213	CcSEcCtD
Pazopanib—Rash—Etidronic acid—Paget's disease of bone	0.00125	0.00212	CcSEcCtD
Pazopanib—Dermatitis—Etidronic acid—Paget's disease of bone	0.00125	0.00211	CcSEcCtD
Pazopanib—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00124	0.00211	CcSEcCtD
Pazopanib—Hypertension—Zoledronate—Paget's disease of bone	0.00124	0.00211	CcSEcCtD
Pazopanib—Headache—Etidronic acid—Paget's disease of bone	0.00124	0.0021	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00123	0.00209	CcSEcCtD
Pazopanib—Anorexia—Pamidronate—Paget's disease of bone	0.00123	0.00208	CcSEcCtD
Pazopanib—Chest pain—Zoledronate—Paget's disease of bone	0.00123	0.00208	CcSEcCtD
Pazopanib—Myalgia—Zoledronate—Paget's disease of bone	0.00123	0.00208	CcSEcCtD
Pazopanib—Arthralgia—Zoledronate—Paget's disease of bone	0.00123	0.00208	CcSEcCtD
Pazopanib—Insomnia—Risedronate—Paget's disease of bone	0.00122	0.00207	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00122	0.00206	CcSEcCtD
Pazopanib—Paraesthesia—Risedronate—Paget's disease of bone	0.00122	0.00206	CcSEcCtD
Pazopanib—Asthenia—Alendronate—Paget's disease of bone	0.00121	0.00205	CcSEcCtD
Pazopanib—Dyspnoea—Risedronate—Paget's disease of bone	0.00121	0.00205	CcSEcCtD
Pazopanib—Dry mouth—Zoledronate—Paget's disease of bone	0.0012	0.00203	CcSEcCtD
Pazopanib—Pruritus—Alendronate—Paget's disease of bone	0.00119	0.00202	CcSEcCtD
Pazopanib—Dyspepsia—Risedronate—Paget's disease of bone	0.00119	0.00202	CcSEcCtD
Pazopanib—Nausea—Etidronic acid—Paget's disease of bone	0.00118	0.00199	CcSEcCtD
Pazopanib—Oedema—Zoledronate—Paget's disease of bone	0.00118	0.00199	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00117	0.00199	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00117	0.00198	CcSEcCtD
Pazopanib—Infection—Zoledronate—Paget's disease of bone	0.00117	0.00198	CcSEcCtD
Pazopanib—Fatigue—Risedronate—Paget's disease of bone	0.00117	0.00198	CcSEcCtD
Pazopanib—LYN—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00116	0.003	CbGpPWpGaD
Pazopanib—Insomnia—Pamidronate—Paget's disease of bone	0.00116	0.00197	CcSEcCtD
Pazopanib—CYP3A4—urine—Paget's disease of bone	0.00116	0.0527	CbGeAlD
Pazopanib—LCK—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.00116	0.00299	CbGpPWpGaD
Pazopanib—Pain—Risedronate—Paget's disease of bone	0.00116	0.00196	CcSEcCtD
Pazopanib—Shock—Zoledronate—Paget's disease of bone	0.00116	0.00196	CcSEcCtD
Pazopanib—Paraesthesia—Pamidronate—Paget's disease of bone	0.00116	0.00196	CcSEcCtD
Pazopanib—Diarrhoea—Alendronate—Paget's disease of bone	0.00115	0.00196	CcSEcCtD
Pazopanib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00115	0.00195	CcSEcCtD
Pazopanib—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00115	0.00195	CcSEcCtD
Pazopanib—Dyspnoea—Pamidronate—Paget's disease of bone	0.00115	0.00194	CcSEcCtD
Pazopanib—Somnolence—Pamidronate—Paget's disease of bone	0.00114	0.00194	CcSEcCtD
Pazopanib—CYP2D6—urine—Paget's disease of bone	0.00114	0.0519	CbGeAlD
Pazopanib—Skin disorder—Zoledronate—Paget's disease of bone	0.00114	0.00193	CcSEcCtD
Pazopanib—LCK—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.00114	0.00295	CbGpPWpGaD
Pazopanib—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00114	0.00193	CcSEcCtD
Pazopanib—Dyspepsia—Pamidronate—Paget's disease of bone	0.00113	0.00192	CcSEcCtD
Pazopanib—Anorexia—Zoledronate—Paget's disease of bone	0.00112	0.0019	CcSEcCtD
Pazopanib—Decreased appetite—Pamidronate—Paget's disease of bone	0.00112	0.0019	CcSEcCtD
Pazopanib—Dizziness—Alendronate—Paget's disease of bone	0.00112	0.00189	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00111	0.00188	CcSEcCtD
Pazopanib—Fatigue—Pamidronate—Paget's disease of bone	0.00111	0.00188	CcSEcCtD
Pazopanib—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00111	0.00188	CcSEcCtD
Pazopanib—LCK—Host Interactions of HIV factors—NUP205—Paget's disease of bone	0.0011	0.00285	CbGpPWpGaD
Pazopanib—PLK4—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.0011	0.00284	CbGpPWpGaD
Pazopanib—Pain—Pamidronate—Paget's disease of bone	0.0011	0.00186	CcSEcCtD
Pazopanib—Vomiting—Alendronate—Paget's disease of bone	0.00107	0.00182	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00107	0.00181	CcSEcCtD
Pazopanib—Abdominal pain—Risedronate—Paget's disease of bone	0.00107	0.00181	CcSEcCtD
Pazopanib—LCK—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00106	0.00275	CbGpPWpGaD
Pazopanib—Rash—Alendronate—Paget's disease of bone	0.00106	0.0018	CcSEcCtD
Pazopanib—Insomnia—Zoledronate—Paget's disease of bone	0.00106	0.0018	CcSEcCtD
Pazopanib—Dermatitis—Alendronate—Paget's disease of bone	0.00106	0.0018	CcSEcCtD
Pazopanib—Headache—Alendronate—Paget's disease of bone	0.00106	0.00179	CcSEcCtD
Pazopanib—Paraesthesia—Zoledronate—Paget's disease of bone	0.00106	0.00179	CcSEcCtD
Pazopanib—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00105	0.00178	CcSEcCtD
Pazopanib—Dyspnoea—Zoledronate—Paget's disease of bone	0.00105	0.00178	CcSEcCtD
Pazopanib—Somnolence—Zoledronate—Paget's disease of bone	0.00105	0.00177	CcSEcCtD
Pazopanib—Dyspepsia—Zoledronate—Paget's disease of bone	0.00103	0.00175	CcSEcCtD
Pazopanib—ITK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.00103	0.00266	CbGpPWpGaD
Pazopanib—Decreased appetite—Zoledronate—Paget's disease of bone	0.00102	0.00173	CcSEcCtD
Pazopanib—Abdominal pain—Pamidronate—Paget's disease of bone	0.00102	0.00172	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00102	0.00172	CcSEcCtD
Pazopanib—Fatigue—Zoledronate—Paget's disease of bone	0.00101	0.00172	CcSEcCtD
Pazopanib—Pain—Zoledronate—Paget's disease of bone	0.00101	0.0017	CcSEcCtD
Pazopanib—Nausea—Alendronate—Paget's disease of bone	0.001	0.0017	CcSEcCtD
Pazopanib—PLK4—Cell Cycle—NUP205—Paget's disease of bone	0.000986	0.00254	CbGpPWpGaD
Pazopanib—Asthenia—Risedronate—Paget's disease of bone	0.000972	0.00165	CcSEcCtD
Pazopanib—FGFR1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00097	0.0025	CbGpPWpGaD
Pazopanib—PDGFRA—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000968	0.0025	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—VCP—Paget's disease of bone	0.000964	0.00249	CbGpPWpGaD
Pazopanib—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000961	0.00163	CcSEcCtD
Pazopanib—Pruritus—Risedronate—Paget's disease of bone	0.000958	0.00162	CcSEcCtD
Pazopanib—LCK—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.000955	0.00246	CbGpPWpGaD
Pazopanib—FGFR3—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000948	0.00244	CbGpPWpGaD
Pazopanib—Abdominal pain—Zoledronate—Paget's disease of bone	0.000929	0.00157	CcSEcCtD
Pazopanib—Diarrhoea—Risedronate—Paget's disease of bone	0.000926	0.00157	CcSEcCtD
Pazopanib—Asthenia—Pamidronate—Paget's disease of bone	0.000924	0.00156	CcSEcCtD
Pazopanib—Pruritus—Pamidronate—Paget's disease of bone	0.000911	0.00154	CcSEcCtD
Pazopanib—Dizziness—Risedronate—Paget's disease of bone	0.000895	0.00152	CcSEcCtD
Pazopanib—Diarrhoea—Pamidronate—Paget's disease of bone	0.000881	0.00149	CcSEcCtD
Pazopanib—Vomiting—Risedronate—Paget's disease of bone	0.000861	0.00146	CcSEcCtD
Pazopanib—UGT1A1—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000856	0.00221	CbGpPWpGaD
Pazopanib—Rash—Risedronate—Paget's disease of bone	0.000854	0.00145	CcSEcCtD
Pazopanib—Dermatitis—Risedronate—Paget's disease of bone	0.000853	0.00144	CcSEcCtD
Pazopanib—Dizziness—Pamidronate—Paget's disease of bone	0.000851	0.00144	CcSEcCtD
Pazopanib—Headache—Risedronate—Paget's disease of bone	0.000848	0.00144	CcSEcCtD
Pazopanib—MAP2K5—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000847	0.00218	CbGpPWpGaD
Pazopanib—Asthenia—Zoledronate—Paget's disease of bone	0.000844	0.00143	CcSEcCtD
Pazopanib—Pruritus—Zoledronate—Paget's disease of bone	0.000832	0.00141	CcSEcCtD
Pazopanib—Vomiting—Pamidronate—Paget's disease of bone	0.000818	0.00139	CcSEcCtD
Pazopanib—Rash—Pamidronate—Paget's disease of bone	0.000812	0.00137	CcSEcCtD
Pazopanib—Dermatitis—Pamidronate—Paget's disease of bone	0.000811	0.00137	CcSEcCtD
Pazopanib—Headache—Pamidronate—Paget's disease of bone	0.000806	0.00137	CcSEcCtD
Pazopanib—Diarrhoea—Zoledronate—Paget's disease of bone	0.000804	0.00136	CcSEcCtD
Pazopanib—Nausea—Risedronate—Paget's disease of bone	0.000804	0.00136	CcSEcCtD
Pazopanib—FGF1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000787	0.00203	CbGpPWpGaD
Pazopanib—Dizziness—Zoledronate—Paget's disease of bone	0.000778	0.00132	CcSEcCtD
Pazopanib—Nausea—Pamidronate—Paget's disease of bone	0.000765	0.0013	CcSEcCtD
Pazopanib—PI4KB—Metabolism—NUP205—Paget's disease of bone	0.000749	0.00193	CbGpPWpGaD
Pazopanib—Vomiting—Zoledronate—Paget's disease of bone	0.000748	0.00127	CcSEcCtD
Pazopanib—Rash—Zoledronate—Paget's disease of bone	0.000741	0.00126	CcSEcCtD
Pazopanib—Dermatitis—Zoledronate—Paget's disease of bone	0.000741	0.00125	CcSEcCtD
Pazopanib—Headache—Zoledronate—Paget's disease of bone	0.000737	0.00125	CcSEcCtD
Pazopanib—ITK—Immune System—NUP205—Paget's disease of bone	0.000735	0.00189	CbGpPWpGaD
Pazopanib—LCK—HIV Infection—NUP205—Paget's disease of bone	0.000717	0.00185	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000711	0.00183	CbGpPWpGaD
Pazopanib—Nausea—Zoledronate—Paget's disease of bone	0.000698	0.00118	CcSEcCtD
Pazopanib—BMPR1B—Signaling Pathways—VCP—Paget's disease of bone	0.000668	0.00172	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000652	0.00168	CbGpPWpGaD
Pazopanib—ITK—Immune System—PML—Paget's disease of bone	0.000649	0.00167	CbGpPWpGaD
Pazopanib—SLCO1B1—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000647	0.00167	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00064	0.00165	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—INPP5D—Paget's disease of bone	0.000639	0.00165	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000628	0.00162	CbGpPWpGaD
Pazopanib—ITK—Immune System—INPP5D—Paget's disease of bone	0.000626	0.00162	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—VCP—Paget's disease of bone	0.000611	0.00158	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000607	0.00157	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000606	0.00156	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000606	0.00156	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000583	0.0015	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000579	0.00149	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000563	0.00145	CbGpPWpGaD
Pazopanib—ITK—Immune System—SQSTM1—Paget's disease of bone	0.000562	0.00145	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—CALCA—Paget's disease of bone	0.000547	0.00141	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000546	0.00141	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000544	0.0014	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000515	0.00133	CbGpPWpGaD
Pazopanib—FGFR3—Disease—VCP—Paget's disease of bone	0.000497	0.00128	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000497	0.00128	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000481	0.00124	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—VCP—Paget's disease of bone	0.000456	0.00118	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000446	0.00115	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000438	0.00113	CbGpPWpGaD
Pazopanib—FGF1—Disease—VCP—Paget's disease of bone	0.000413	0.00107	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—NUP205—Paget's disease of bone	0.000412	0.00106	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000398	0.00103	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000391	0.00101	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00039	0.00101	CbGpPWpGaD
Pazopanib—FGFR3—Disease—NUP205—Paget's disease of bone	0.00038	0.000981	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—CALCA—Paget's disease of bone	0.000379	0.000978	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—INPP5D—Paget's disease of bone	0.000378	0.000974	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000371	0.000957	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—INPP5D—Paget's disease of bone	0.00037	0.000955	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000366	0.000945	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—PML—Paget's disease of bone	0.000364	0.000939	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000357	0.000921	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—INPP5D—Paget's disease of bone	0.000351	0.000906	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—VCP—Paget's disease of bone	0.000348	0.000899	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—CALCA—Paget's disease of bone	0.000347	0.000895	CbGpPWpGaD
Pazopanib—FGF1—Immune System—NUP205—Paget's disease of bone	0.000342	0.000883	CbGpPWpGaD
Pazopanib—FGFR2—Disease—VCP—Paget's disease of bone	0.000342	0.000883	CbGpPWpGaD
Pazopanib—KIT—Disease—VCP—Paget's disease of bone	0.000336	0.000867	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000333	0.00086	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000329	0.000848	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000326	0.000842	CbGpPWpGaD
Pazopanib—FGFR1—Disease—VCP—Paget's disease of bone	0.000319	0.000823	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—VCP—Paget's disease of bone	0.000318	0.00082	CbGpPWpGaD
Pazopanib—FGF1—Disease—NUP205—Paget's disease of bone	0.000316	0.000815	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—SQSTM1—Paget's disease of bone	0.000315	0.000812	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—VCP—Paget's disease of bone	0.000311	0.000803	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—INPP5D—Paget's disease of bone	0.00031	0.000799	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000304	0.000785	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—VCP—Paget's disease of bone	0.000303	0.000783	CbGpPWpGaD
Pazopanib—FGF1—Immune System—PML—Paget's disease of bone	0.000302	0.00078	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000295	0.000761	CbGpPWpGaD
Pazopanib—FGF1—Immune System—INPP5D—Paget's disease of bone	0.000292	0.000753	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—VCP—Paget's disease of bone	0.00029	0.000747	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—VCP—Paget's disease of bone	0.000287	0.000739	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—NUP205—Paget's disease of bone	0.000283	0.000731	CbGpPWpGaD
Pazopanib—FGFR3—Disease—CALCA—Paget's disease of bone	0.000282	0.000728	CbGpPWpGaD
Pazopanib—KIT—Immune System—NUP205—Paget's disease of bone	0.000278	0.000717	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000268	0.00069	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000266	0.000687	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—NUP205—Paget's disease of bone	0.000264	0.000681	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—NUP205—Paget's disease of bone	0.000263	0.000679	CbGpPWpGaD
Pazopanib—FGF1—Immune System—SQSTM1—Paget's disease of bone	0.000262	0.000675	CbGpPWpGaD
Pazopanib—FGFR2—Disease—NUP205—Paget's disease of bone	0.000261	0.000675	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—CALCA—Paget's disease of bone	0.000259	0.000667	CbGpPWpGaD
Pazopanib—KIT—Disease—NUP205—Paget's disease of bone	0.000257	0.000662	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—PML—Paget's disease of bone	0.00025	0.000646	CbGpPWpGaD
Pazopanib—KIT—Immune System—PML—Paget's disease of bone	0.000246	0.000634	CbGpPWpGaD
Pazopanib—FGFR1—Disease—NUP205—Paget's disease of bone	0.000244	0.000629	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—NUP205—Paget's disease of bone	0.000243	0.000627	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—INPP5D—Paget's disease of bone	0.000242	0.000623	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VCP—Paget's disease of bone	0.00024	0.000618	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—NUP205—Paget's disease of bone	0.000237	0.000612	CbGpPWpGaD
Pazopanib—KIT—Immune System—INPP5D—Paget's disease of bone	0.000237	0.000612	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VCP—Paget's disease of bone	0.000235	0.000607	CbGpPWpGaD
Pazopanib—FGF1—Disease—CALCA—Paget's disease of bone	0.000235	0.000605	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—PML—Paget's disease of bone	0.000233	0.000602	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—PML—Paget's disease of bone	0.000233	0.0006	CbGpPWpGaD
Pazopanib—LYN—Immune System—NUP205—Paget's disease of bone	0.000232	0.000599	CbGpPWpGaD
Pazopanib—LCK—Disease—VCP—Paget's disease of bone	0.00023	0.000593	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—INPP5D—Paget's disease of bone	0.000225	0.000581	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—INPP5D—Paget's disease of bone	0.000225	0.000579	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VCP—Paget's disease of bone	0.000223	0.000576	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VCP—Paget's disease of bone	0.000223	0.000575	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—NUP205—Paget's disease of bone	0.000219	0.000565	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—SQSTM1—Paget's disease of bone	0.000216	0.000558	CbGpPWpGaD
Pazopanib—KIT—Immune System—SQSTM1—Paget's disease of bone	0.000213	0.000548	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—PML—Paget's disease of bone	0.00021	0.000541	CbGpPWpGaD
Pazopanib—LYN—Immune System—PML—Paget's disease of bone	0.000205	0.000529	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000204	0.000525	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—INPP5D—Paget's disease of bone	0.000202	0.000522	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—SQSTM1—Paget's disease of bone	0.000202	0.000521	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—SQSTM1—Paget's disease of bone	0.000201	0.000519	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VCP—Paget's disease of bone	0.000201	0.000518	CbGpPWpGaD
Pazopanib—LYN—Immune System—INPP5D—Paget's disease of bone	0.000198	0.000511	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CALCA—Paget's disease of bone	0.000198	0.00051	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VCP—Paget's disease of bone	0.000196	0.000507	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CALCA—Paget's disease of bone	0.000194	0.000501	CbGpPWpGaD
Pazopanib—KIT—Disease—CALCA—Paget's disease of bone	0.000191	0.000492	CbGpPWpGaD
Pazopanib—LCK—Immune System—NUP205—Paget's disease of bone	0.00019	0.000491	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000182	0.000469	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—SQSTM1—Paget's disease of bone	0.000181	0.000468	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CALCA—Paget's disease of bone	0.000181	0.000467	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CALCA—Paget's disease of bone	0.00018	0.000465	CbGpPWpGaD
Pazopanib—LYN—Immune System—SQSTM1—Paget's disease of bone	0.000178	0.000458	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000177	0.000457	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CALCA—Paget's disease of bone	0.000177	0.000456	CbGpPWpGaD
Pazopanib—LCK—Disease—NUP205—Paget's disease of bone	0.000176	0.000453	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CALCA—Paget's disease of bone	0.000172	0.000444	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000169	0.000437	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000169	0.000436	CbGpPWpGaD
Pazopanib—LCK—Immune System—PML—Paget's disease of bone	0.000168	0.000434	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—NUP205—Paget's disease of bone	0.000168	0.000433	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000165	0.000425	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CALCA—Paget's disease of bone	0.000164	0.000424	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CALCA—Paget's disease of bone	0.000163	0.000419	CbGpPWpGaD
Pazopanib—LCK—Immune System—INPP5D—Paget's disease of bone	0.000162	0.000419	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VCP—Paget's disease of bone	0.000161	0.000415	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—NUP205—Paget's disease of bone	0.000154	0.000397	CbGpPWpGaD
Pazopanib—LCK—Immune System—SQSTM1—Paget's disease of bone	0.000146	0.000375	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—INPP5D—Paget's disease of bone	0.000143	0.00037	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—NUP205—Paget's disease of bone	0.000143	0.000368	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00014	0.000361	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000137	0.000355	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CALCA—Paget's disease of bone	0.000136	0.000351	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CALCA—Paget's disease of bone	0.000133	0.000344	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—INPP5D—Paget's disease of bone	0.000131	0.000339	CbGpPWpGaD
Pazopanib—LCK—Disease—CALCA—Paget's disease of bone	0.00013	0.000337	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00013	0.000337	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00013	0.000336	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CALCA—Paget's disease of bone	0.000127	0.000327	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CALCA—Paget's disease of bone	0.000126	0.000326	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—INPP5D—Paget's disease of bone	0.000122	0.000314	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000118	0.000304	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000117	0.000302	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000115	0.000296	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CALCA—Paget's disease of bone	0.000114	0.000294	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CALCA—Paget's disease of bone	0.000111	0.000288	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—SQSTM1—Paget's disease of bone	9.41e-05	0.000243	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CALCA—Paget's disease of bone	9.14e-05	0.000236	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NUP205—Paget's disease of bone	8.85e-05	0.000228	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NUP205—Paget's disease of bone	7.71e-05	0.000199	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—INPP5D—Paget's disease of bone	7.55e-05	0.000195	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NUP205—Paget's disease of bone	7.26e-05	0.000187	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—INPP5D—Paget's disease of bone	6.57e-05	0.00017	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—INPP5D—Paget's disease of bone	6.19e-05	0.00016	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NUP205—Paget's disease of bone	6.15e-05	0.000159	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—INPP5D—Paget's disease of bone	5.25e-05	0.000135	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	4.75e-05	0.000123	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	4.05e-05	0.000104	CbGpPWpGaD
